Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study. [electronic resource]
Producer: 20040920Description: 414-9 p. digitalISSN:- 0939-5555
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- analysis
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biomarkers
- Bleomycin -- administration & dosage
- Cohort Studies
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Female
- Humans
- Ki-67 Antigen -- analysis
- Leucovorin -- administration & dosage
- Life Tables
- Lymphoma, Large B-Cell, Diffuse -- chemistry
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Neoplasm Proteins -- analysis
- Neoplastic Stem Cells -- chemistry
- Norway -- epidemiology
- Prednisone -- administration & dosage
- Prognosis
- Proto-Oncogene Proteins c-bcl-2 -- analysis
- Risk Factors
- Survival Analysis
- Sweden -- epidemiology
- Treatment Outcome
- Tumor Suppressor Protein p53 -- analysis
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.